NBIX vs. HIMS
Compare and contrast key facts about Neurocrine Biosciences, Inc. (NBIX) and Hims & Hers Health, Inc. (HIMS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBIX or HIMS.
Key characteristics
| NBIX | HIMS | |
|---|---|---|
| YTD Return | -3.48% | 213.26% |
| 1Y Return | 18.66% | 309.40% |
| 3Y Return (Ann) | 13.13% | 55.97% |
| 5Y Return (Ann) | 2.78% | 23.88% |
| Sharpe Ratio | 0.40 | 3.99 |
| Sortino Ratio | 0.72 | 4.03 |
| Omega Ratio | 1.12 | 1.51 |
| Calmar Ratio | 0.49 | 4.44 |
| Martin Ratio | 1.23 | 17.10 |
| Ulcer Index | 10.93% | 18.74% |
| Daily Std Dev | 32.91% | 80.46% |
| Max Drawdown | -97.21% | -87.29% |
| Current Drawdown | -16.96% | 0.00% |
Fundamentals
| NBIX | HIMS | |
|---|---|---|
| Market Cap | $12.88B | $5.11B |
| EPS | $3.75 | $0.44 |
| PE Ratio | 33.91 | 53.20 |
| Total Revenue (TTM) | $2.24B | $1.24B |
| Gross Profit (TTM) | $2.20B | $963.54M |
| EBITDA (TTM) | $614.00M | $44.51M |
Correlation
The correlation between NBIX and HIMS is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NBIX vs. HIMS - Performance Comparison
In the year-to-date period, NBIX achieves a -3.48% return, which is significantly lower than HIMS's 213.26% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NBIX vs. HIMS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NBIX vs. HIMS - Dividend Comparison
Neither NBIX nor HIMS has paid dividends to shareholders.
Drawdowns
NBIX vs. HIMS - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for NBIX and HIMS. For additional features, visit the drawdowns tool.
Volatility
NBIX vs. HIMS - Volatility Comparison
The current volatility for Neurocrine Biosciences, Inc. (NBIX) is 9.02%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 33.84%. This indicates that NBIX experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NBIX vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Neurocrine Biosciences, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities